Form 4 for MED MEDIFAST INC
Accepted 2026-03-27 00:00:00 ET · period of report 2026-03-13 · accession 0001628280-26-021797 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-03-27 | 2026-03-13+ | MED | MacKenzie Jonathan Barrett | VP, CAO, Fin | F - Tax | $9.62 | -1,130 | 10.0K | -10% | -$10.9K |
| 2026-03-27 | 2026-03-25 | MED | MacKenzie Jonathan Barrett | VP, CAO, Fin | A - Grant | $0.00 | +10.8K | 20.8K | +108% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-17 | F | D | 70 | $10.05 | 10,870 | D | — | — | (F1) Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day. |
| 2 | Common | Common Stock | 2026-03-13 | F | D | 198 | $9.62 | 10,940 | D | — | — | (F1) Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day. |
| 3 | Common | Common Stock | 2026-03-25 | F | D | 862 | $9.59 | 10,008 | D | — | — | (F1) Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day. |
| 4 | Common | Common Stock | 2026-03-25 | A | A | 10,830 | $0.00 | 20,838 | D | — | — | (F2) Represents a grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in three equal annual installments beginning on the first anniversary of the grant date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. |